Private companies who have a significant stake must be disappointed along with institutions after Scilex Holding Companys market cap dropped by US22m
| SCLX Stock | 0.32 0.01 3.03% |
Slightly above 62% of Scilex Holding's investor base is looking to short. The analysis of overall sentiment of trading Scilex Holding stock suggests that many investors are alarmed at this time. Scilex Holding's investing sentiment can be driven by a variety of factors including economic data, Scilex Holding's earnings reports, geopolitical events, and overall market trends.
Scilex |
Key Insights Significant control over Scilex Holding by private companies implies that the general public has more...
Read at simplywall.st
 |
Scilex Holding Fundamental Analysis
We analyze Scilex Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scilex Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scilex Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Scilex Holding is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Scilex Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scilex Holding stock to make a market-neutral strategy. Peer analysis of Scilex Holding could also be used in its relative valuation, which is a method of valuing Scilex Holding by comparing valuation metrics with similar companies.
Peers
Scilex Holding Related Equities
| BMY | Bristol Myers | 3.67 | ||||
| AMGN | Amgen | 2.21 | ||||
| MRK | Merck | 1.98 | ||||
| ABBV | AbbVie | 0.99 | ||||
| AZN | AstraZeneca PLC | 0.94 | ||||
| LLY | Eli Lilly | 0.88 | ||||
| BIIB | Biogen | 0.45 | ||||
| GSK | GlaxoSmithKline PLC | 0.22 | ||||
| GILD | Gilead Sciences | 0.07 | ||||
| NVS | Novartis | 0.12 | ||||
| SNY | Sanofi ADR | 1.30 |
Additional Tools for Scilex Stock Analysis
When running Scilex Holding's price analysis, check to measure Scilex Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scilex Holding is operating at the current time. Most of Scilex Holding's value examination focuses on studying past and present price action to predict the probability of Scilex Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scilex Holding's price. Additionally, you may evaluate how the addition of Scilex Holding to your portfolios can decrease your overall portfolio volatility.